89 related articles for article (PubMed ID: 18556410)
1. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
Di Marco V; Capra M; Gagliardotto F; Borsellino Z; Cabibi D; Barbaria F; Ferraro D; Cuccia L; Ruffo GB; Bronte F; Di Stefano R; Almasio PL; Craxì A
Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410
[TBL] [Abstract][Full Text] [Related]
2. Desferioximine induced Ototoxicity in Thalassemic patients.
Vir D; Panda NK; Marwaha RK
Ann Neurosci; 2010 Oct; 17(4):182-4. PubMed ID: 25205902
[TBL] [Abstract][Full Text] [Related]
3. Does Splenectomy Influence the Development of Hypothyroidism in Transfusion Dependent Thalassemia Patients? A Retrospective Study.
Skafida M; Sofocleous C; Kattamis A; Kattamis C
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019064. PubMed ID: 31700589
[No Abstract] [Full Text] [Related]
4. The Pancreatic changes affecting glucose homeostasis in transfusion dependent β- thalassemia (TDT): a short review.
De Sanctis V; Soliman A; Tzoulis P; Daar S; Fiscina B; Kattamis C
Acta Biomed; 2021 Jul; 92(3):e2021232. PubMed ID: 34212898
[TBL] [Abstract][Full Text] [Related]
5. The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major.
Rostami T; Kasaeian A; Maleki N; Nikbakht M; Kiumarsi A; Tavangar SM; Taheri APH; Mousavi SA; Ghavamzadeh A
Stem Cell Res Ther; 2021 Mar; 12(1):213. PubMed ID: 33781314
[TBL] [Abstract][Full Text] [Related]
6. Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders.
Ruiz I; Fourati S; Ahmed-Belkacem A; Rodriguez C; Scoazec G; Donati F; Soulier A; Demontant V; Poiteau L; N'Debi M; François M; Chevaliez S; Pawlotsky JM
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e191-e196. PubMed ID: 33208686
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence.
Mangia A; Bellini D; Cillo U; Laghi A; Pelle G; Valori VM; Caturelli E
BMC Gastroenterol; 2020 Aug; 20(1):251. PubMed ID: 32746786
[TBL] [Abstract][Full Text] [Related]
8. HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives.
Maffei L; Sorrentino F; Caprari P; Taliani G; Massimi S; Risoluti R; Materazzi S
Front Mol Biosci; 2020; 7():7. PubMed ID: 32118034
[TBL] [Abstract][Full Text] [Related]
9. A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience.
De Sanctis V; Soliman AT; Daar S; Alansary N; Kattamis A; Skafida M; Galati MC; Christou S; Campisi S; Messina G; Yassin MA; Canatan D; Di Maio S; Al Jaouni S; Raiola G; Karimi M; Kaleva V; Kakkar S; Mariannis D; Kattamis C
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020006. PubMed ID: 31934316
[TBL] [Abstract][Full Text] [Related]
10. Thalassemia and hepatocellular carcinoma: links and risks.
Marsella M; Ricchi P
J Blood Med; 2019; 10():323-334. PubMed ID: 31572038
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major.
Mehta R; Kabrawala M; Nandwani S; Desai P; Bhayani V; Patel S; Parekh V
J Clin Exp Hepatol; 2018 Mar; 8(1):3-6. PubMed ID: 29743790
[TBL] [Abstract][Full Text] [Related]
12. Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
Zachou K; Arvaniti P; Gatselis NK; Azariadis K; Papadamou G; Rigopoulou E; Dalekos GN
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017003. PubMed ID: 28101309
[TBL] [Abstract][Full Text] [Related]
13. Liver Enzymes in Children with beta-Thalassemia Major: Correlation with Iron Overload and Viral Hepatitis.
Salama KM; Ibrahim OM; Kaddah AM; Boseila S; Ismail LA; Hamid MM
Open Access Maced J Med Sci; 2015 Jun; 3(2):287-92. PubMed ID: 27275237
[TBL] [Abstract][Full Text] [Related]
14. Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.
El Sayed SM; Baghdadi H; Abou-Taleb A; Mahmoud HS; Maria RA; Ahmed NS; Helmy Nabo MM
J Blood Med; 2014; 5():219-37. PubMed ID: 25382989
[TBL] [Abstract][Full Text] [Related]
15. IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.
Di Marco V; Bronte F; Calvaruso V; Capra M; Borsellino Z; Maggio A; Renda MC; Pitrolo L; Lo Pinto MC; Rizzo M; Fiorenza F; Gerardi C; Grimaudo S; Di Cristina A; Levrero M; Craxì A
Haematologica; 2012 May; 97(5):679-86. PubMed ID: 22180419
[TBL] [Abstract][Full Text] [Related]
16. The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.
Persico M; Bruno S; Costantino A; Mazza M; Almasio PL
Int J Hepatol; 2011; 2011():314301. PubMed ID: 22164334
[TBL] [Abstract][Full Text] [Related]
17. Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.
Ricerca BM; Di Girolamo A; Rund D
Mediterr J Hematol Infect Dis; 2009 Dec; 1(1):e2009028. PubMed ID: 21415996
[TBL] [Abstract][Full Text] [Related]
18. Normal red blood cells partially decrease diepoxybutane-induced chromosome breakage in cultured lymphocytes from Fanconi anaemia patients.
Porto B; Sousa R; Malheiro I; Gaspar J; Rueff J; Gonçalves C; Barbot J
Cell Prolif; 2010 Dec; 43(6):573-8. PubMed ID: 21039995
[TBL] [Abstract][Full Text] [Related]
19. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.
Kell DB
Arch Toxicol; 2010 Nov; 84(11):825-89. PubMed ID: 20967426
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C.
Sood A; Sobti P; Midha V; Singla D; Kaur A; Kaushal S; Sood N; Mittal R; Puri S
Indian J Gastroenterol; 2010 Mar; 29(2):62-5. PubMed ID: 20443101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
